BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7953744)

  • 21. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
    Roh JL; Jang H; Kim EH; Shin D
    Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia.
    Tomimoto H; Akiguchi I; Wakita H; Kimura J; Hori K; Yodoi J
    Brain Res; 1993 Oct; 625(1):1-8. PubMed ID: 7694770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
    Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
    PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione.
    Harper R; Wu K; Chang MM; Yoneda K; Pan R; Reddy SP; Wu R
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):178-85. PubMed ID: 11509327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ADF/TRX and its inhibitor on the release of major basic protein from human eosinophils.
    Koyanagi H; Wakasugi N; Yoshimatsu K; Takashima Y; Yodoi J; Momoi M; Suda T; Kasahara T; Yamaguchi Y
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1140-7. PubMed ID: 7654231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina.
    Ohira A; Honda O; Gauntt CD; Yamamoto M; Hori K; Masutani H; Yodoi J; Honda Y
    Lab Invest; 1994 Feb; 70(2):279-85. PubMed ID: 8139268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
    Dierickx PJ
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW; Beyers KL
    Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 2-methoxyestradiol, buthionine sulfoximine and hydrogen peroxide on the viability of renal carcinoma cell lines (ACHN and ACVB).
    Hirai Y; Kawabe N; Tsuda Y; Miyamoto S; Iwakawa S
    Biol Pharm Bull; 2006 May; 29(5):1064-7. PubMed ID: 16651749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mercaptoethanol protects glutathione depleted cells.
    Chen PC; Gaetjens E; Broome JD
    Agents Actions; 1987 Oct; 22(1-2):171-5. PubMed ID: 3687595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of eosinophil migration by adult T cell leukemia-derived factor.
    Hori K; Hirashima M; Ueno M; Matsuda M; Waga S; Tsurufuji S; Yodoi J
    J Immunol; 1993 Nov; 151(10):5624-30. PubMed ID: 8228251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
    Kang YJ
    Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPM2 channel protective properties of N-acetylcysteine on cytosolic glutathione depletion dependent oxidative stress and Ca2+ influx in rat dorsal root ganglion.
    Özgül C; Nazıroğlu M
    Physiol Behav; 2012 May; 106(2):122-8. PubMed ID: 22300897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
    Iwata S; Hori T; Sato N; Ueda-Taniguchi Y; Yamabe T; Nakamura H; Masutani H; Yodoi J
    J Immunol; 1994 Jun; 152(12):5633-42. PubMed ID: 8207197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells.
    Chiba T; Takahashi S; Sato N; Ishii S; Kikuchi K
    Eur J Immunol; 1996 May; 26(5):1164-9. PubMed ID: 8647182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.